–
TESTS: Covid-19 tests are analyzed at a laboratory in Paris. Photo : THOMAS SAMSON / AFP / NTB
–
Aavitsland says they are still working on the report. He says they do not want to make models in the report that are not completely unlikely.
However, the superior says that they have a “significant concern” about the corona situation in Norway.
In an updated risk assessment on Tuesday, FHI said that the omicron variant could create a “significant disease burden” in December and January.
Many infected and sick by Christmas Eve
The risk assessment states that the omicron variant will become dominant by January 2022.
Aavitsland believes it will become dominant in “a few weeks”, both in Norway, Europe and in the rest of the world .
– It provides an extra, big challenge. It spreads much more and will be able to infect many more, and it cares less if you have been vaccinated, says Aavitsland.
– How will the spread of infection be compared with the delta variant?
– We expect omikron to spread more and faster than delta to spread. More will be infected. But many of us are vaccinated and protected from serious illness, even though we are not well protected from being infected.
– What will this look like when we get to Christmas Eve?
– It is difficult to say, but I am afraid there will be quite a few who are infected and ill, and that the number of hospitalized will be a good deal higher than today, says Aavitsland.
–
PROBABLY NOT USEFUL: Even with a new virus variant, researchers believe that the vaccines the world ’s population has taken protect against serious illness. Photo : CLODAGH KILCOYNE / Reuters / NTB
–
– Helps little
According to doctors in South Africa , where the omicron infection has spread rapidly in recent weeks, the variant causes milder illness, fewer hospitalizations and deaths.
According to Pfizer and Biontech, their vaccine provides good protection against the omicron variant if a third dose is given. Three doses will provide as good protection against omicron as two doses provide against the delta variant, the companies announced on Wednesday.
Researchers believe that there is little risk that the vaccines we have today will be useless. At present, it seems that vaccinated people are becoming less seriously ill.
Nevertheless, the researchers believe it is important to test how quickly companies can turn around and produce a reformulated vaccine with a documented effect.
– Maybe the variant is a little milder for both those who are vaccinated and not. However, it helps little when so many more are infected, says Aavitsland in FHI and refers to the capacity in the health care system.
–